13/08/2026
The ALLG AMLM28 ADAPT trial is exploring new ways to improve outcomes for older people living with acute myeloid leukaemia (AML).
Led by Professor Andrew Wei and Dr Chyn Chua, this innovative study aims to personalise treatment based on how a patient's disease responds, helping to deliver the right treatment at the right time.
As an adaptive platform trial, AMLM28 can evolve as new evidence emerges, creating opportunities to test new treatments and improve patient care.
Learn more about ALLG's research and clinical trials: https://www.allg.org.au/clinical-trials-research/current-clinical-trials/.